Literature DB >> 29574698

Biphasic effects of THC in memory and cognition.

Edward J Calabrese1, Alberto Rubio-Casillas2.   

Abstract

A generally undesired effect of cannabis smoking is a reversible disruption of short-term memory induced by delta-9-tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. However, this paradigm has been recently challenged by a group of scientists who have shown that THC is also able to improve neurological function in old animals when chronically administered at low concentrations. Moreover, recent studies demonstrated that THC paradoxically promotes hippocampal neurogenesis, prevents neurodegenerative processes occurring in animal models of Alzheimer's disease, protects from inflammation-induced cognitive damage and restores memory and cognitive function in old mice. With the aim to reconcile these seemingly contradictory facts, this work will show that such paradox can be explained within the framework of hormesis, defined as a biphasic dose-response.
© 2018 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Alzheimer's disease; biphasic dose response; cannabis; delta-9-tetrahydrocannabinol; hormesis; neuroprotection

Mesh:

Substances:

Year:  2018        PMID: 29574698     DOI: 10.1111/eci.12920

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  23 in total

Review 1.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

Review 2.  Interaction of Cannabis Use and Aging: From Molecule to Mind.

Authors:  Hye Bin Yoo; Jennifer DiMuzio; Francesca M Filbey
Journal:  J Dual Diagn       Date:  2019-09-30

Review 3.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

Review 4.  Aging circadian rhythms and cannabinoids.

Authors:  Erik L Hodges; Nicole M Ashpole
Journal:  Neurobiol Aging       Date:  2019-03-25       Impact factor: 4.673

5.  [Cannabinoids reduce opioid use in older patients with pain : Retrospective three-year analysis of data from a general practice].

Authors:  K Gastmeier; A Gastmeier; F Rottmann; T Herdegen; R Böhm
Journal:  Schmerz       Date:  2022-04-06       Impact factor: 1.107

Review 6.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

Review 7.  Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.

Authors:  Rowan Saloner; Jerel Adam Fields; Maria Cecilia Garibaldi Marcondes; Jennifer E Iudicello; Sofie von Känel; Mariana Cherner; Scott L Letendre; Marcus Kaul; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-15       Impact factor: 4.147

8.  The Effects of Cannabis Use on Cognitive Function in Healthy Aging: A Systematic Scoping Review.

Authors:  Nina Pocuca; T Jordan Walter; Arpi Minassian; Jared W Young; Mark A Geyer; William Perry
Journal:  Arch Clin Neuropsychol       Date:  2021-07-19       Impact factor: 2.813

Review 9.  Hormesis in Health and Chronic Diseases.

Authors:  Xin Li; Tingting Yang; Zheng Sun
Journal:  Trends Endocrinol Metab       Date:  2019-09-11       Impact factor: 12.015

10.  Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration.

Authors:  M Galán-Ganga; C Rodríguez-Cueto; J Merchán-Rubira; F Hernández; J Ávila; M Posada-Ayala; J L Lanciego; E Luengo; M G Lopez; A Rábano; J Fernández-Ruiz; I Lastres-Becker
Journal:  Acta Neuropathol Commun       Date:  2021-05-17       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.